Sector revisions DexCom, Inc.

Stocks

Market Closed - Nasdaq 21:00:00 21/08/2026 BST			5-day change	1st Jan Change
92.34 ^USD	+2.35%		+2.89%	+39.13%

08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
08-04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	DEXCOM, INC.							25
	ABBOTT LABORATORIES							25
	MEDTRONIC PLC							25
	CENCORA, INC.							13
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							12
	MEDLINE INC.							26
	WEST PHARMACEUTICAL SERVICES, INC.							15
	TERUMO CORPORATION							13
	STERIS PLC							8
	SARTORIUS STEDIM BIOTECH							14
	ZIMMER BIOMET HOLDINGS, INC.							21
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	BAXTER INTERNATIONAL INC.							11
	GLOBUS MEDICAL, INC.							13
	ALIGN TECHNOLOGY, INC.							15
	INSULET CORPORATION							22
	REPLIGEN CORPORATION							20
	BIO-RAD LABORATORIES, INC.							5
	Average							16
	Weighted average by Cap.							19